Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

cAMP-elevating agents suppress dendritic cell function.

T Kambayashi1, R P Wallin, H G Ljunggren

  • 1Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden.

Journal of Leukocyte Biology
|December 12, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes.

Journal of internal medicine·2019
Same author

Crystal structures and transistor properties of phenyl-substituted tetrathiafulvalene derivatives.

Nanotechnology·2011
Same author

Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice.

Leukemia·2006
Same author

[Experience with thoracoscopy for rifle gunshot penetrating trauma of the chest; report of a case].

Kyobu geka. The Japanese journal of thoracic surgery·2005
Same author

[Giant hemangioma in the neck extending into the mediastinum required a second operation after 39 years; report of a case].

Kyobu geka. The Japanese journal of thoracic surgery·2005
Same author

Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.

Leukemia·2003

cAMP-elevating agents, including rolipram, reduce dendritic cell (DC) function. These agents suppress tumor necrosis factor alpha release and antigen presentation, potentially explaining their effectiveness in treating autoimmune and inflammatory diseases.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Dendritic cells (DCs) are crucial in autoimmune and inflammatory conditions.
  • cAMP-elevating agents influence various inflammatory and autoimmune diseases.

Purpose of the Study:

  • To investigate the specific effects of cAMP-elevating agents on dendritic cell (DC) function.
  • To elucidate the mechanisms underlying DC modulation by these agents.

Main Methods:

  • Treatment of DCs with cAMP-elevating agents (8-Bromo cAMP, prostaglandin E(2), 3-isobutyl-1-methylxanthine, rolipram).
  • Measurement of tumor necrosis factor alpha release and antigen presentation.
  • Assessment of interleukin-10 (IL-10) production and major histocompatibility complex type II (MHC II) expression.
  • Use of phosphodiesterase inhibitors and neutralizing antibodies against IL-10.

Related Experiment Videos

Main Results:

  • cAMP-elevating agents dose-dependently inhibited tumor necrosis factor alpha release and antigen presentation by DCs.
  • Rolipram, a phosphodiesterase type 4 inhibitor, mimicked these effects.
  • Decreased antigen presentation correlated with increased IL-10 production and reduced MHC II expression.
  • IL-10 neutralization reversed the inhibition of antigen presentation and MHC II expression.

Conclusions:

  • cAMP-elevating agents, particularly via phosphodiesterase type 4 inhibition, suppress DC function.
  • The observed effects are mediated, at least in part, by an IL-10-dependent mechanism.
  • These findings provide a mechanistic basis for the therapeutic use of agents like rolipram in autoimmune and inflammatory diseases.